For Evolution Health Group, 2022 proved something of a challenging year. After years of consistent growth, revenue nudged downward by 3%, to $32.6 million from $33.6 million in 2021. The company ...

BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its ...

BATON ROUGE, La., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, announced today that it has ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. At Health Evolution, we are committed to driving ...

Today’s technological and digital innovations are changing healthcare. Handheld devices and wearables, telehealth options, better data management, AI—these innovations are helping to streamline ...

Evolution Health Group might have fallen short on meeting 2023’s revenue growth target of 30%, but a nearly 20% increase amid a chaotic economic environment is certainly not the worst consolation ...